|
Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma |
Dana-Farber Cancer Institute |
Flashes of Hope |
|
Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |
|
DNA Sequencing Using Malaria Slides |
Indiana University |
Northwestern Mutual Foundation |
|
Next-Generation Personalized Neuroblastoma Therapy (Nepenthe) |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine |
Northwestern Mutual Foundation |
|
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan |
Northwestern Mutual Foundation |
|
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center |
Northwestern Mutual Foundation |
|
Optimizing Engager T-cells for CD19+ Malignancies |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Development of Targeted Leukemia Inhibitors Using Nanoparticle Delivery |
University of Massachusetts Medical School |
I Care I Cure |
|
Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation |
